We found that bacterial infections were higher in CD19 CAR-T recipients, as previously reported [9–12], supporting our conclusion that higher viral infections after CD30 CAR-T did not likely reflect more frequent viral testing during the pandemic. Here, CD19 is linked to bacterial infectious disease.